Admin Core
Admin Core
批准号:
10709003
负责人:
Louis J. Picker
金额:
$20.17万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-22 至 2027-06-30
关键词:
Advisory CommitteesChargeCommunicationCytomegalovirusDatabasesDecision MakingEnsureFosteringGrantHIVHumanHuman ResourcesImmunologicsInstitutionLeadershipMaintenanceManuscriptsNational Institute of Allergy and Infectious DiseasePhaseProgram Research Project GrantsProgress ReportsQualifyingQuality ControlReportingSIV VaccinesScientific Advances and AccomplishmentsScientific EvaluationScientistStatistical Data InterpretationSupervisionTravelUnited States National Institutes of HealthVisitWritingclinical developmentcollaborative environmentdata curationdata sharingmeetingsprogramsresearch clinical testingsuccessvectorvector vaccinevideoconference
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CORE A PROJECT SUMMARY
The purpose of Core A (Administrative Core) is to provide the organizational framework to optimally implement
the multi-project research program proposed in this Program Project application, a grant that seeks to understand
the unique “replication arrest” efficacy of 68-1 RhCMV-based Simian Immunodeficiency virus (SIV) vaccine
vectors as a guide to downstream clinical development of the Human Cytomegalovirus (HCMV)/ Human
Immunodeficiency virus (HIV) vectors that are currently in Phase 1 clinical testing. This framework will provide
scientific leadership and integration of the Program, as well as administrative support and assistance to the
Program Director and Project Leaders. This support and assistance includes providing logistical support on
administrative and clerical matters, facilitating interactions between Project and Core Leaders and providing a
forum for decision making, database maintenance and administration, data curation and sharing, experimental
planning, statistical analysis, regulatory compliance assistance, manuscript writing and submission, progress
report submission, and financial tracking and management, as well as organizing an external advisory committee
to evaluate the progress and overall direction of the program.
The specific aims of this Core are:
1. To ensure an interactive environment and foster a cohesive, focused relationship among Program scientists
and to provide a forum for Project and Core Leaders to set overall priorities and make key decisions via
regular meetings and videoconferences.
2. To promote scientific advancement of the Program by establishing an external advisory committee (EAC) to
review the progress of the program, and provide independent scientific and clinical development oversight.
3. To provide fiscal oversight and general administrative, budgetary, database, and statistical support for the
overall program,
4. To maintain communication with the NIAID program officer and other NIAID staff, coordinate reports to the
NIH and EAC and ensure compliance with NIH and local institutional requirements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Systemic analysis of the origin and tissue effects of the 68-1 RhCMV/SIV vaccine efficacy-predictive whole blood transcriptomic signature
-
批准号:10723639
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2023
-
负责人:Louis J. Picker
-
依托单位:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
-
批准号:10619297
-
项目类别:
-
资助金额:$498.32万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
-
批准号:10709020
-
项目类别:
-
资助金额:$47.15万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Admin Core
-
批准号:10619298
-
项目类别:
-
资助金额:$20.35万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
-
批准号:10709002
-
项目类别:
-
资助金额:$503.93万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Project 3: Determination of the minimal MHC-E-restricted SIV epitope targeting required for RhCMV/SIV vaccine-mediated SIV replication arrest efficacy
-
批准号:10619304
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2022
-
负责人:Louis J. Picker
-
依托单位:
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
-
批准号:9883700
-
项目类别:
-
资助金额:$232.2万
-
财政年份:2017
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8227957
-
项目类别:
-
资助金额:$81.28万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
ROLE OF MEMORY T CELL DYNAMICS IN SIV INFECTION
-
批准号:8357743
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8416334
-
项目类别:
-
资助金额:$75.91万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8681307
-
项目类别:
-
资助金额:$337.74万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8880099
-
项目类别:
-
资助金额:$334.24万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
ASSESSMENT OF PD-I BLOCKADE AS A NEW IMMUNOTHERAPEUTIC APPROACH TO AIDS
-
批准号:8357789
-
项目类别:
-
资助金额:$12.18万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8140904
-
项目类别:
-
资助金额:$85.6万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
IMMUNE CORRELATES OF PROTECTION AGAINST SIV INFECTION
-
批准号:8357770
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development of an Effector-Memory T Cell AIDS Vaccine
-
批准号:8495905
-
项目类别:
-
资助金额:$338.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
HARNESSING INNATE IMMUNITY TO ENHANCE T-CELL INDUCING HIV VACCINES
-
批准号:8357757
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
REJUVENATION OF THE T-CELL COMPARTMENT IN AGING PRIMATES
-
批准号:8357808
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
CMV VECTOR DESIGN AND DEVELOPMENT
-
批准号:8357756
-
项目类别:
-
资助金额:$24.36万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
-
批准号:8608474
-
项目类别:
-
资助金额:$83.12万
-
财政年份:2011
-
负责人:Louis J. Picker
-
依托单位:
国内基金
海外基金
CHARGE综合征致病基因CHD7介导的三维转录调控网络研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:朱艳芬
-
依托单位:
Sema3E在CHARGE综合症中的作用及机制研究
-
批准号:81160144
-
项目类别:地区科学基金项目
-
资助金额:52.0万元
-
批准年份:2011
-
负责人:徐洪
-
依托单位: